Please login to the form below

Not currently logged in
Email:
Password:

Medicare

This page shows the latest Medicare news and features for those working in and with pharma, biotech and healthcare.

Novartis sues US government over Medicare drug price negotiation programme

Novartis sues US government over Medicare drug price negotiation programme

Administration (FDA) to treat heart failure, with around 587, 000 Medicare patients taking the drug every year. ... Collectively, the drugs accounted for more than $45bn in Medicare Part D spending from June 2022 to May 2023, according to the CMS.

Latest news

  • US government announces first ten drugs subject to Medicare pricing negotiations US government announces first ten drugs subject to Medicare pricing negotiations

    The IRA allows Medicare, the government health plan for older adults, to negotiate lower prices for a selected group of prescription medicines. ... Collectively, the drugs accounted for more than $45bn in Medicare Part D spending from June 2022 to May

  • AstraZeneca latest to sue US government over Medicare drug price negotiation plan AstraZeneca latest to sue US government over Medicare drug price negotiation plan

    AstraZeneca (AZ) has sued the US government over “critical aspects” of the Medicare drug price negotiation element of President Biden's Inflation Reduction Act (IRA). ... The IRA allows Medicare, the government health plan for older adults, to

  • Being the change Being the change

    Innovation reduction. The deep dive was about the implications of the Inflation Reduction Act, the recent US legislation that allows Medicare to negotiate the prices of some innovative drugs. ... Stepping back. We began by putting the act in perspective.

  • Boehringer sues US government over Medicare drug price negotiation programme Boehringer sues US government over Medicare drug price negotiation programme

    The IRA allows Medicare, the government health plan for older adults, to negotiate lower prices for a selected group of prescription medicines. ... The drugmaker also alleges that the programme does not involve “genuine negotiations” between drug

  • Tooth and nail Tooth and nail

    For some context, the Inflation Reduction Act (IRA), which was passed in 2022, gives Medicare the right to negotiate some (not all) drug prices with manufacturers. ... Lawyers from both Merck and BMS claim that the Medicare-negotiation programme is

More from news
Approximately 13 fully matching, plus 168 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 9 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
SEVEN STONES COLLECTIVE

Hello. We are the Total Health creative agency. It’s our collective mix of talent that gets us to truly different...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....